Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pretreatment Aceclofenac for Post-Endodontic Pain
NCT03335007Phase 3Completed
- Sponsor
- Cairo University
- Start
- May 2015
- Primary completion
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of aceclofenac in irreversible pulpitis, sponsored by Cairo University. Started May 2015; status: completed.
02
Drugs
aceclofenac
03
Conditions
irreversible pulpitis
Beyond the preview
Go deeper on NCT03335007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03335007.